Restless Legs at Menopause: Why They Got Worse, Not Started

Why did your restless legs get worse at menopause, not start?

Ghorayeb and colleagues (2007) put questions to 536 women who met the clinical criteria for restless legs syndrome, all of them members of the French patient association, and asked how their symptoms had changed across the events of their reproductive lives. The answers came back lopsided.

One number stands out.

• 69 percent reported their symptoms worsened following menopause
• 29 percent of the women who had not yet reached menopause said symptoms worsened during their periods
• 23 percent said symptoms worsened during pregnancy

That middle group matters as much as the headline. Every woman in that survey already had restless legs before the menopause question was asked. What the survey tracked was severity changing, which is a different event from a condition arriving.

What a worsening pattern rules out

A condition that switches on at 51 and a condition that has been running thin for 30 years look nothing alike, and they cannot share an explanation.

An on and off history says the tendency was always there and that something kept tipping it back under the surface. A reserve that finally empties accounts for both halves of that story. A brand new disease at 51 accounts for neither, and it contradicts the lives of most of the women who have it.

The survey authors drew a careful conclusion and it is worth repeating rather than hiding. They wrote that female hormonal changes do not account for the variation in perceived severity, and that a hormonal role in the underlying disease is unlikely. We agree with them. The hormone on its own was never the whole story.

What does a dopamine signal actually need to work?

Restless legs is not a muscle that will not relax. It is a shortage of a brain chemical called dopamine, which at night carries the signal that tells your legs to be still.

A signal only works if 2 things work. Something has to send it, and something has to receive it.

The sending side runs on iron

Your brain builds dopamine using one rate limiting enzyme called tyrosine hydroxylase, and that enzyme runs on iron. Less iron reaching the cells that manufacture dopamine means less dopamine made, and less signal to send.

The part almost nobody is told is that the iron in your blood and the iron that reaches your brain are 2 different numbers. Earley and colleagues (2000) at Johns Hopkins measured ferritin in the spinal fluid of restless legs patients at 1.11 nanograms per milliliter against 3.50 in age matched controls, while serum readings showed no meaningful difference between the groups at all.

Connor and colleagues (2003) then examined brain tissue directly and found iron and its storage protein markedly reduced in the region tied to restless legs, along with fewer of the receptors that pull iron into those cells. That is a delivery problem, not a supply problem.

The receiving side runs on estrogen

Dopamine that does get made still has to be heard, and estrogen is what keeps the receiving end tuned.

Almey and colleagues (2015) traced estrogen receptors to the cell membranes of brain regions fed by dopamine inputs, including the dorsal striatum and the nucleus accumbens, areas researchers had long assumed held very few of them. Yoest and colleagues (2018) reviewed what happens when the hormone moves. Estradiol enhances dopamine release and changes how dopamine receptors bind.

That work is laboratory and animal research. It describes the machinery, and it does not promise that putting the hormone back gets a woman's legs back, which is the next question and one that has actually been studied.

Set the usual answers against the 2 halves and the gaps show up quickly.

Why did hormone therapy not settle your legs?

This is the question that breaks the simple version of the story, so it deserves the real answer rather than a sidestep.

Wesström and colleagues (2008) sent questions on restless legs, general health, sleep, reproductive health and menopausal state to a random sample of 5,000 Swedish women aged 18 to 64. The response rate was 70.3 percent, 15.7 percent of respondents met the criteria for restless legs, and prevalence climbed with age.

Two findings sat side by side in that paper. Restless legs ran strongly with the hot flashes and night sweats of the menopause transition, and there was no statistical relationship between hormone replacement use and restless legs.

Under a one cause hormone story, that second finding is fatal.

Under a 2 input story it is the strongest evidence on the page, because it explains itself. Restoring the receiving side changes nothing while nothing is being broadcast. The antenna goes back up and there is still no signal arriving for it to catch.

Being precise about this study matters, because it is easy to over read in either direction.

• It is a prevalence survey of the general population rather than a treatment trial, so it cannot tell you what the hormone did to one particular woman's legs
• The association it found was with vasomotor symptoms, meaning the transition itself, and not with simply being postmenopausal
• It measured hormone use and symptoms and never measured receptor function, so it cannot settle the receiving side in either direction

Worth saying plainly before we go near the product. Shilajit is not a hormone and it does not add estrogen to you. Fulvic acid supports the body's own estrogen signaling, which is a different thing from hormone replacement and is not a substitute for it.

Why did iron pills not settle them either?

The supply side has its own version of the same trap, and it starts years before the last period.

The transition years are when bleeding often turns heaviest and least predictable. Cycles stop running on a schedule, the lining builds up unopposed, and what follows is a flood rather than a period. Munro and colleagues (2023) state the consequence without hedging. Heavy menstrual bleeding is highly prevalent and a major contributor to iron deficiency and its most severe form, iron deficiency anemia, and its insidious nature means it gets normalized by everyone involved, including the woman living through it.

So the drain is real, and it lands in exactly the decade the symptoms tighten.

Then the bleeding stops for good and blood iron climbs back toward normal on its own, because that is what blood does once the losses end. Her legs get worse anyway. Up or down, the number in her blood was never the number her legs were following.

What a normal ferritin does and does not settle

A normal blood panel answers one question and leaves the important one open.

• Earley's group found the spinal fluid deficit in patients whose serum ferritin matched the controls, so a normal blood number is precisely what that research would predict
• Trenkwalder and colleagues (2017) gave a single intravenous dose of iron to 110 patients who were iron deficient but not anemic, and severity fell against placebo by week 12
• Connor's group found fewer of the receptors that carry iron into brain cells, which is why adding more iron upstream does not automatically move the number that matters

None of that makes an iron pill pointless, and none of it turns brain iron into something a clinic can measure on a Tuesday morning. It says the bottleneck is delivery, and a standard panel was never built to see it.

Where does shilajit fit, and where does it not?

Start with the boundary, because it is absolute. No human trial has ever given shilajit to people with restless legs and measured what happened. Every study above was run on restless legs patients directly, using spinal fluid, brain tissue, intravenous iron and population surveys, and not one of them involved shilajit.

What shilajit is, honestly, is a purified resin from the Altai mountains carrying fulvic acid and more than 80 trace minerals, iron among them, in food form. Fulvic acid's documented role is as a mineral carrier, a molecule built to bind mineral ions and move them across membranes, a property surveyed by Stohs (2014) in his review of shilajit's composition and safety.

The closest thing to a direct test is an animal one. Velmurugan and colleagues (2010) gave shilajit to rats in 2 models of iron deficiency anemia and saw hemoglobin, hematocrit and red cell counts rise significantly against untreated animals. That is a rat, it measured blood counts rather than iron stores, and it says nothing whatsoever about brain iron or about legs.

Where the bridge holds and where it stops

It holds in one narrow place and stops immediately after.

• The pathway this research keeps naming is mineral delivery running downstream of estrogen signaling, and that is the pathway shilajit's own research measures
• Sharing a mechanism with a condition is not the same as being tested against it
• Shilajit is a food form mineral resin, not a concentrated iron dose and not a hormone
• Nobody has given a woman shilajit and measured her brain iron, her dopamine or her nights, so nothing here is a restless legs result
• Anyone telling you shilajit treats or cures restless legs is inventing it

Across every human study ever run on shilajit, zero serious adverse events have been reported. Optimum is a small family owned company out of Florida, the resin comes from the Altai mountains, and every batch is third party lab tested twice over, for heavy metals and for mycotoxins, with the results posted where anyone can read them.

Optimum Shilajit

If the mineral and estrogen signaling pathway in this article is the one you want supported, in food form, with fulvic acid as the carrier and the trace minerals that come with it, here is .

See Optimum Shilajit